Rhenman & Partners Asset Management’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $1.24M | Hold |
|
|||||
|
2022
Q3 | $2.07M | Hold |
|
|||||
|
2022
Q2 | $2.09M | Sell |
|
|||||
|
2022
Q1 | $3.31M | Sell |
|
|||||
|
2021
Q4 | $13.3M | Hold |
|
|||||
|
2021
Q3 | $17.1M | Hold |
|
|||||
|
2021
Q2 | $16.3M | Sell |
|
|||||
|
2021
Q1 | $26.1M | Sell |
|
|||||
|
2020
Q4 | $22.9M | Buy |
|
|||||
|
2020
Q3 | $16.6M | Buy |
|
|||||
|
2020
Q2 | $18.3M | Sell |
|
|||||
|
2020
Q1 | $19.2M | Sell |
|
|||||
|
2019
Q4 | $23.7M | Sell |
|
|||||
|
2019
Q3 | $21.9M | Buy |
|
|||||
|
2019
Q2 | $25.8M | Sell |
|
|||||
|
2019
Q1 | $24.7M | Buy |
|
|||||
|
2018
Q4 | $16.9M | Buy |
|
|||||
|
2018
Q3 | $18.6M | Sell |
|
|||||
|
2018
Q2 | $30.2M | Buy |
|
|||||
|
2018
Q1 | $22M | Sell |
|
|||||
|
2017
Q4 | $21.1M | Sell |
|
|||||
|
2017
Q3 | $20.8M | Buy |
|
|||||
|
2017
Q2 | $15.5M | Buy |
|
|||||
|
2017
Q1 | $11M | Buy |
|
|||||
|
2016
Q4 | $5.03M | Buy |
|
|||||
|
2016
Q3 | $6.7M | Sell |
|
|||||
|
2016
Q2 | $6.69M | Sell |
|
|||||
|
2016
Q1 | $7.22M | Sell |
|
|||||
|
2015
Q4 | $9.79M | Sell |
|
|||||
|
2015
Q3 | $7.54M | Sell |
|
|||||
|
2015
Q2 | $11.7M | Sell |
|
|||||
|
2015
Q1 | $11M | Buy |
|
|||||
|
2014
Q4 | $3.69M | Sell |
|
|||||
|
2014
Q3 | $6.13M | Buy |
|
|||||
|
2014
Q2 | $3.33M | Buy |
|
|||||
|
2014
Q1 | $2.2M | Sell |
|
|||||
|
2013
Q4 | $2.16M | Buy |
|